Logos Global Management »

United Therapeutics Corporation shares owned by Logos Global Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Logos Global Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $24M 85k 287.35

More positions owned by Logos Global Management

Spdr Series Trust S&p Biotech Call Option (XBI)
Ideaya Biosciences (IDYA)
Akero Therapeutics (AKRO)
Revolution Medicines (RVMD)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Disc Medicine (IRON)
Arvinas Ord Call Option (ARVN)
Janux Therapeutics Call Option (JANX)
Avidity Biosciences Ord (RNA)
Keros Therapeutics (KROS)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Biogen Idec (BIIB)
United Therapeutics Corporation (UTHR)
Ocular Therapeutix (OCUL)
Erasca (ERAS)

View all positions for Logos Global Management

Top funds holding United Therapeutics Corporation

BlackRock
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Dimensional Fund Advisors
LMR Partners
Henderson Group

View all funds holding United Therapeutics Corporation